/ Print /

PHARMACY BEST PRACTICES

Three Pricing Models That Address the High-Cost Gene, Cell Therapies
Three Pricing Models That Address the High-Cost Gene, Cell TherapiesHere are three innovative structures in pricing models to address the high-cost of curative therapies.
How to Treat Substance Abuse with a Model of Ongoing Care
How to Treat Substance Abuse with a Model of Ongoing CareHere's how one federally qualified health center in southcentral Pennsylvania is tackling the opioid crisis in its community.
The Blood Pressure Drugs that are Linked to Lower Mortality
The Blood Pressure Drugs that are Linked to Lower MortalityA study from the Intermountain Medical Center Heart Institute has shocking findings about certain blood pressure medications and mortality outcomes.
Top 10 AMCP Sessions Health Execs Should Attend
Top 10 AMCP Sessions Health Execs Should AttendAttending the AMCP Managed Care and Specialty Pharmacy Annual Meeting in Boston April 23 to April 26? Here are our top session recommendations.
Payers Seize Opportunities to Control Diabetes Drug Costs
Payers Seize Opportunities to Control Diabetes Drug CostsDiabetes drug spending is on the rise, but there are ways to control it.
Do Preferred Pharmacy Networks Save Money for Part D Beneficiaries?
Do Preferred Pharmacy Networks Save Money for Part D Beneficiaries?A new Oliver Wyman reveals costly findings about Part D beneficiaries enrolled in plans without preferred pharmacy networks.
News You Should Know: 3 Takeaways from Top Managed Care Articles MarchWe know you’re pressed for time, so we’re here to help. Listen to this two-minute podcast for critical takeaways from three of our top articles.
Opinion: Time to Manage ‘Clinically Superfluous’ Drug Products to Control CostsPBMs are in a unique position to leverage three critical tools to protect patients from unnecessary healthcare costs.
Will PBMs Be the Next Target of Opioid Lawsuits?Experts weigh in on a recent lawsuit against PBMs, whether similar lawsuits will crop up, and the likely outcomes.
Global Genetic-Based Database Ramps UpThe new global DNA registry could help enable more precise treatments and identify who’s at risk for certain health problems.